ROLE OF ANDROGRAPHIS PANICULATA ON ALTERED STEROIDOGENESIS AND OXIDATIVE IMPAIRMENT IN OVARY OF MICE SUBJECTED TO ARSENIC INTOXICATION
HTML Full TextROLE OF ANDROGRAPHIS PANICULATA ON ALTERED STEROIDOGENESIS AND OXIDATIVE IMPAIRMENT IN OVARY OF MICE SUBJECTED TO ARSENIC INTOXICATION
Dimple M. Damore * 1 and Mandava V. Rao 2
Department of Zoology 1, Bhavan’s Sheth R. A. College of Science, Gujarat University, Ahmedabad -380001, Gujarat, India.
Department of Zoology 2, School of Sciences, Gujarat University, Ahmedabad - 380009, Gujarat, India.
ABSTRACT: The present study was designed to determine the role of Andrographis paniculata (AP; 50 mg/kg) against the oxidative stress caused by the arsenic (0.5 and 1.0 mg/kg) for 30 days in adult mice. The results of in-vivo studies demonstrated that arsenic treatment resulted in a significant dose-dependent increase in the ovarian arsenic level and lipid peroxidation (LPO), followed by a marked reduction in gravimetric data, levels of total ascorbic acid, glutathione and in the activities of superoxide dismutase, catalase, and glutathione peroxidase. A significant reduction in the activities of 3b and 17b hydroxysteroid dehydrogenases along with elevated levels of cholesterol indicated ovarian endocrine dysfunction. These results suggest that an increase in free radical formation relative to loss of antioxidant defense system during arsenic exposure may render ovary more susceptible to oxidative damage leading to their functional inactivation. On the other hand, co-administration of arsenic with Andrographis paniculata (AP) restored altered biochemical variables, antioxidant balance, and gravimetry which suggests that the free radical-mediated damage during arsenic-induced oxidative stress could have been ameliorated by A. paniculata (AP) by its anti-oxidative potential.
Keywords: |
Arsenic, Oxidative stress, Steroidogenesis, Andrographis paniculata, Mice
INTRODUCTION: Inorganic arsenic compounds are well known for their high toxicity. Natural contamination of groundwater by arsenic has become a critical water quality problem in many parts of the world, particularly in Southeast Asia. Today, chronic low-dose arsenic exposure via drinking water presents a major concern because it affects human populations and causes severe biochemical and pathological problems such as hyperkeratosis, black foot disease, cardiovascular disease, diabetes mellitus and cancer of the liver, kidney, lung and bladder 1, 2.
Inorganic arsenic increases the rate of formation of reactive oxygen species including superoxide anion radical and hydroxyl radical through a chain reaction 3. It has further been demonstrated that reactive oxygen species are directly involved in oxidative damage to many cellular components such as lipids, proteins, and DNA in cells exposed to arsenic, which can ultimately lead to cell death 4, 5. Most cases of human exposure to arsenic compounds result from natural environmental source like drinking water, in which it is difficult to remove the source of contamination then inclusion of protective factors in the diet may be useful to prevent arsenic toxicity 6.
Antioxidants play an important role against the reactive oxygen species (ROS). Reports indicate that there is an inverse relationship between the dietary intake of an antioxidant and the incidence of human diseases. Hence, the search for natural antioxidant is essentially important. Andrographis paniculata (Family: Acanthaceae), a native plant in Southeast Asia, has been widely used in traditional medicine to treat various chronic and infectious diseases. It has been demonstrated a number of different pharmacological actions in in-vitro and animal studies 7. Anticancer 8, immunomodulatory, anti-inflammatory 9, antipyretic, hepatoprotective 10, 11, hypoglycemic 12, antiplatelet and antioxidant 10, 12 activities have all been reported 13. Since, AP extract contains diterpenoids, flavonoids, and steroids of which diterpene lactones (andrographolides) are the main components and have been reported to contain various therapeutic efficacies 14, 15, 16. Hence, the present study aimed to evaluate the possible pharmacological role of AP in arsenic mediated ovarian dysfunction.
MATERIALS AND METHODS:
Animals: Healthy, adult female albino mice (Mus musculus) of Swiss strain weighing between 30-35 gm were procured under the Animal Maintenance and Registration No. 167/1999/ CPCSEA from the Ministry of Social Justice and Empowerment, Government of India. All the animals were acclimatized seven days prior to the commencement of the treatment. They were housed in an air-conditioned animal house at a temperature of 26 ± 2 °C and exposed to 10-12 h of daylight and relative humidity of 30-70%. Animals of different groups were caged separately and were maintained on standard chow (National Institute of Occupational Health (NIOH), containing wheat 70%, gram-20%, fish meat - 5% and yeast powder - 5%) and water was given ad libitum.
Treatments: Arsenic trioxide (As2O3) was purchased from Hi-Media Laboratories Ltd., Mumbai, India, and Andrographis paniculata (AP) was obtained from Natural Remedies, Bangalore, India. A stock solution of arsenic trioxide was prepared in double-distilled water and given to mice with feeding tube attached to a hypodermic syringe. Both the doses for arsenic are derived from its LD50 value 17.
Animals were divided into following five groups: Group I served as untreated (control), Group II was orally given 0.5 mg/kg by. wt As2O3 (Low dose-LD) while Group III was orally treated with 1 mg/kg by. wt As2O3 (High dose- HD) for 30 days. Group IV was given 50 mg/kg by wt Andrographis paniculata only. Animals in Group V were orally administrated 1 mg As2O3/kg + 50 mg/kg AP. At the end of each treatment, the animals were weighed and then sacrificed using light ether anesthesia. The ovary of mice was dissected out carefully, blotted free of blood and weighed up to the nearest milligram and used for the different assays.
Lipid peroxidation (LPO) was determined by the method of Ohkawa et al.18 The activities of catalase (CAT; E.C.1.11.1.6) and superoxide dismutase (SOD; E.C.1.15.11) were analyzed by the modified method of Luck 19 and spectrophotometric method of Kakkar et al., 20 respectively and glutathione (GSH) was estimated by the method of Grunert & Philips 21. The activity of glutathione peroxidase (GPx; E.C.1.11.19) was assayed by the modified method of Pagila & Valentine 22. Protein levels were estimated by the method of Lowry et al., 23 and total ascorbic acid (TAA) was assessed by the method of Roe & Kuether 24. Cholesterol level was analyzed by the method of Zlatkis et al., 25 3b-hydroxy steroid dehydrognase and 17 b-hydroxysteroid dehydrognase were measured according to the method Talalay 26. Asenic retention was estimated by Arsenic Test kit obtained from Germany. For all biochemical estimations a minimum of 8 replicates was done for each parameter. Data were statistically analyzed using the student's t-test.
RESULTS: Arsenic exposure caused a significant (p<0.001) reduction in body and organ weights of arsenic-treated groups. The groups treated with arsenic alone showed arsenic deposition in the ovary when compared with the control group. Upon treatment with AP, a marked recuperation in gravimetric values and the elementary arsenic content in the ovary were observed in Table 1. Ovarian 3b and 17b hydroxysteroid dehydrogenase (HSDs) activities had a significant (p<0.01) decrease accompanied by a marked (p<0.001) elevation in cholesterol levels. A significant (p<0.001) drop in the ovarian protein content was also observed in arsenic-treated groups. In this study, the altered level of steroidogenic parameters and protein content were restored significantly with AP supplementation Table 2.
TABLE 1: GRAVIMETRIC PARAMETERS & ARSENIC RETENTION IN ARSENIC AND ANDROGRAPHIS PANICULATA EXPOSED MICE
Group-1 | Group-2 | Group-3 | Group-4 | Group-5 | |
Body weight (gm) | 31.25±0.52 | 25.50±0.33ϯ | 24.75±0.23ϯ | 30.50±0.33ns | 28.75±0.52ns |
Organ weight (gm) | 12.81±0.36 | 8.13±0.34ϯ | 5.31±0.34ϯ | 12.31±0.23ns | 11.18±0.40ns |
Arsenic levels (µg/100mg) | 0.00 | 0.01 | 0.05 | 0.00 | 0.005 |
(Values are mean ± SE from 8 animals in each group). P-values: *<0.05; ** <0.01; ϯ˂0.001 ns Not significant when compared with control group. Group 1 – Control, Group 2 – Arsenic (Low dose), Group 3 – Arsenic (High dose), Group 4 – Andrographic paniculata, Group 5 – Arsenic + Andrographic paniculata.
TABLE 2: EFFECT OF ANDROGRAPHIS PANICULATA ON STEROIDOGENIC & METABOLIC PARAMETERS IN THE OVARY OF ARSENIC EXPOSED FEMALE MICE
Group-1 | Group-2 | Group-3 | Group-4 | Group-5 | |
Cholesterol (mg/100 mg) | 8.29±0.25 | 15.48±0.31ϯ | 19.68±0.46ϯ | 8.78±0.37ns | 8.85 ±0.33ns |
3b HSD (mg androstenedione
formed/ mg protein/min) |
0.44±0.07 | 0.24±0.06* | 0.19±006* | 0.43±0.10ns | 0.39±0.10ns |
17b HSD (mg androstenedione
formed/ mg protein/min) |
0.40±0.05 | 0.21±0.06* | 0.16±006* | 0.41±0.07ns | 0.37±0.05ns |
Protein (mg/100 mg) | 14.52±0.26 | 11.89±0.24ϯ | 10.67±0.37ϯ | 14.77±0.29ns | 13.73±0.40ns |
(Values are mean ± SE from 8 animals in each group). P-values: *<0.05; ** <0.01; ϯ˂0.001 ns Not significant when compared with control group. Group 1 – Control, Group 2 – Arsenic (Low dose), Group 3 – Arsenic (High dose), Group 4 – Andrographic paniculata, Group 5 – Arsenic + Andrographic paniculata.
The lipid peroxidation levels recorded a marked (p<0.001) increase in the ovary of arsenic-treated groups. Exposure of arsenic further led to a significant (p<0.001; p<0.01) depletion in GSH levels and in the activities of SOD, CAT, and GPx in treated mice. Similarly arsenic treatment brought about a remarkable (p<0.001) reduction in the TAA levels. Co-treatment with AP extract significantly restored the altered levels of these indices to metalloid treated groups Table 3.
TABLE 3: EFFECT OF ANDROGRAPHIS PANICULATA ON OXIDATIVE STRESS AND RELATED PARAMETERS IN THE OVARY OF ARSENIC EXPOSED FEMALE MICE
Group-1 | Group-2 | Group-3 | Group-4 | Group-5 | |
LPO (MDA/mg/60 min) | 52.65±0.55 | 74.52±0.50ϯ | 104.22±1.06ϯ | 51.72±0.55ns | 53.44±0.69ns |
GSH (µg/100 mg) | 36.99±0.55 | 21.92±0.68ϯ | 19.93±0.56ϯ | 35.97±0.67ns | 36.01±0.58ns |
GPx (nanomoles of NADPH Oxidised/mg protein | 5.95±0.24 | 3.11±0.26ϯ | 2.06±0.29ϯ | 5.40±0.28ns | 5.19±0.23ns |
CAT (µg/H2O2) consumed/ mg protein/min) | 11.12±0.51 | 8.41±0.56ϯ | 7.20±0.56ϯ | 11.45±0.47ns | 10.60±0.50ns |
SOD (Units/mg protein) | 2.13±0.22 | 1.72±0.28ϯ | 1.21±0.18ϯ | 2.09±0.22ϯ | 1.95±0.27ϯ |
TAA (mg/gm) | 2.01±0.14 | 1.64±0.07ϯ | 0.98±0.15ϯ | 1.98±0.09ϯ | 1.90±0.09ϯ |
(Values are expressed as mean ± SE from 8 animals in each group). P-values: *<0.05; ** <0.01; ϯ˂0.001 ns Not significant when compared with control group. Group 1 – Control, Group 2 – Arsenic (Low dose), Group 3 – Arsenic (High dose), Group 4 – Andrographic paniculata, Group 5 – Arsenic + Andrographic paniculata.
DISCUSSION: Reduction in body weight reflects a variety of responses including rejection of food or water because of treatment induced anorexia. In arsenic treated groups, body and organ weights were significantly decreased with respect to control indicating the systemic toxicity. The weight loss of the female organ in arsenic-treated animals may be due to the possibility of low hormonal levels 27, 28.
These reduced gravimetric values thus indicated the lethal nature of the toxicant. Corroborating with the present study Rao and Avani 28 also reported altered gravimetric and arsenic retention in arsenic-treated animals. Since the production of reactive oxygen species is high in reproductive tissue due to active metabolism and steroidogenesis, the tissue is under continuous oxidative stress. The result of the present investigation demonstrated the adverse effect of arsenic treatment on female gonadal steroidogenesis and antioxidant defense mechanism 29. In ovarian steroidogenesis 3b and 17b - HSDs are the key regulatory enzymes, the suppressed activities of these enzymes along with elevated cholesterol levels by arsenic suggest alteration in its hormone synthesis 27, 30, 31.
This is in agreement with the previous findings where arsenic treatment was associated with inhibition of ovarian steroidogenesis 27, 32, 33. To minimize the risk caused by ROS, supplementation of Andrographis paniculata in arsenic-treated mice resulted in a significant increase in ovarian enzyme activities and reduction in cholesterol levels. Altered protein levels in ovary also induced changes leading to biochemical defects, structural disorders and altered physiological functions. A number of sulfhydryl containing proteins and enzyme systems have been found to be altered by exposure to arsenic 33. Thus a significant reduction in protein level in our study indicates toxicity status of the tissue by arsenic which binds to -SH groups leading to protein synthesis inhibition 34.
Lipid peroxidation is regarded as one of the basic mechanisms of tissue damage caused by free radicals. The enzymatic antioxidants SOD, CAT, and GPx counteract the free radical and reduce the oxidative stress. SOD accelerates the conversion of superoxide radicals to hydrogen peroxide while CAT or GPx converts hydrogen peroxide to water. An increase in LPO level was presumably associated with increased free radicals, confirming the fact that the free radicals reduced the antioxidant status in ovary of arsenic-treated mice 35. The observed alterations might be attributed to the utilization of these antioxidants to alleviate free radical-induced oxidative stress 36.
Earlier studies also suggest that ROS produced due to arsenic treatment leads to the generation of oxidative stress 37. Glutathione is a tripeptidyl molecule and is present in either the reduced (GSH) or the oxidized state (GSSG) by forming a disulfide bond between two molecules. It has pleiotropic roles, which includes the maintenance of cells in a reduced state and the formation of conjugates with some harmful endogenous and xenobiotic compounds. In our study, glutathione levels were found to be decreased significantly. This reduction is suggested to be due to the consumption of glutathione while protecting against the arsenic-induced oxidative stress.
Cellular toxicity of arsenic was also found to be inversely related to intracellular GSH levels and thus may be enhanced by GSH depletion 38. Ascorbic acid is known to be a powerful reducing agent, which helps in activating several enzymes, and acts as an antioxidant for detoxifying toxic substances. A decrease in level of TAA under arsenic-induced stress suggested that the ascorbic acid is rapidly oxidized in the ovary. In support of our data, studies by Chinoy 33 reported altered ascorbate metabolism in the ovary by arsenic treatment. In the present study administration of extract of Andrographis paniculata in arsenic treated mice found to enhance the steroidogenic and antioxidant indices which were drastically reduced in the arsenic treated animals suggest that arsenic induced ovarian damage and functions were reversed by extract possibly through its pharmacological activities 39, 40, 41.
The protective role may be due to the direct reaction of compounds of Andrographis with free radicals 42, 44 and showed remarkable retrieval in body and organ weights, regulate the enzymic and non-enzymic antioxidant defenses and other metabolic indices along with a reduction in arsenic levels of ovary 45. Studies by Kishore et al., 46, 47 also reported that AP inhibits the formation of oxygen-derived free radicals and normalized the level of antioxidant indices 48. Thus, it is evident that adult female mice of Swiss strain on chronic oral exposure to arsenic developed oxidative stress to cause detrimental effects on the ovarian functions. But simultaneous administration of the Andrographis paniculata extract enhanced the antioxidant defense system and functions of the ovary in female mice.
ACKNOWLEDGEMENT: Nil
CONFLICT OF INTEREST: Nil
REFERENCES:
- Mazumder DG: Health effects chronic arsenic toxicity. In Handbook of Arsenic Toxicology. Academic Press 2015: 137-77.
- Mandal P: Molecular insight of arsenic-induced carcinogenesis and its prevention. Naunyn-Schmiedeberg's Archives of Pharmacology 2017; 390(5): 443-55.
- Ellinsworth DC: Arsenic, reactive oxygen, and endothelial dysfunction. Journal of Pharmacology and Experimental Therapeutics 2015; 353(3): 458-64.
- Kim S and Ryu DY: A short review of arsenic-induced toxicity. Journal of the Preventive Veterinary Medicine 2016; 40(1): 46-52.
- Khairul I, Wang QQ, Jiang YH, Wang C and Naranmandura H: Metabolism, toxicity and anticancer activities of arsenic compounds. Oncotarget 2017; 8(14): 23905.
- Hettick BE, Canas-Carrell JE, French AD and Klein DM: Arsenic: a review of the element’s toxicity, plant interactions, and potential methods of remediation. Journal of Agricultural & Food Chemistry 2015; 63(32): 7097-07.
- Dai Y, Chen SR, Chai L, Zhao J, Wang Y and Wang Y: Overview of pharmacological activities of Andrographis paniculata and its major compound andrographolide. Critical Reviews in Food Science and Nutrition 2019; 59: S17-29.
- Islam MT, Ali ES, Uddin SJ, Islam MA, Shaw S, Khan IN, Saravi SS, Ahmad S, Rehman S, Gupta VK and Găman MA: Andrographolide, a diterpene lactone from Andrographis paniculata and its therapeutic promises in cancer. Cancer Letters 2018; 420: 129-45.
- Low M, Khoo CS, Münch G, Govindaraghavan S and Sucher NJ: An in-vitro study of anti-inflammatory activity of standardized Andrographis paniculata extracts and pure andrographolide. BMC Complementary and Alternative Medicine 2015; 15(1): 18.
- Puri SK, Habbu PV, Kulkarni PV and Kulkarni VH: Evaluation of endophytic fungal fractions of Andrographis paniculata (Burm. f.) Wall. Nees leaves for in-vitro free radical scavenging and hepatoprotective activity. International Journal of Research in Pharmaceutical Sciences 2018; 9(1): 1-17.
- Puri SK, Habbu PV, Kulkarni PV and Kulkarni VH: Hepatoprotective activity of fungal endophytic fractions of Andrographis paniculata (Burm. f.) Wall Nees. leaves in paracetamol and ethanol-induced hepatotoxicity. International Journal of Pharmaceutical Sciences and Research 2019; 10(1): 97-107.
- Rajakumar G, Thiruvengadam M, Mydhili G, Gomathi T and Chung IM: Green approach for synthesis of zinc oxide nanoparticles from Andrographis paniculata leaf extract and evaluation of their antioxidant, anti-diabetic, and anti-inflammatory activities. Bioprocess and Biosystems Engineering 2018; 41(1): 21-30.
- Nyeem MA, Mannan MA, Nuruzzaman M, Kamrujjaman KM and Das SK: Indigenous king of bitter (Andrographis paniculata): A review. Journal of Medicinal Plants 2017; 5(2): 318-24.
- Rajasekaran A, Arivukkarasu R and Mathew L: A systematic comprehensive review on therapeutic potential of Andrographis paniculata (Burm. f.) Wall. ex Nees. Journal of Pharmacognosy and Phytochemistry 2016; 5(5): 189.
- Maity GN, Maity P, Dasgupta A, Acharya K, Dalai S and Mondal S: Structural and antioxidant studies of a new arabinoxylan from green stem Andrographis paniculata (Kalmegh). Carbohydrate Polymers 2019; 212: 297-03.
- Kurzawa M, Filipiak-Szok A, Kłodzińska E and Szłyk E: Determination of phytochemicals, antioxidant activity and total phenolic content in Andrographis paniculata using chromatographic methods. Journal of Chromatography B 2015; 995: 101-6.
- Harrison JW: Acute oral toxicity and chemical and physical properties of arsenic trioxides. Arch Ind Health 1958; 17: 118-23.
- Ohkawa H, Ohishi N and Yagi K: Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Analytical Biochemistry 1979; 95(2): 351-8.
- Luck H: Catalase, in methods of enzyme analysis. Academic Press, New York, 1971: 885.
- Kakkar P, Das B and Viswanathan PN: A modified spectrophotometric assay of superoxide dismutase. Indian J Biochem Biophys 1984; 21: 130.
- Grunert RR and Philips P H: A modification of nitroprusside method of analysis for glutathione. Ach. Biochem. Biophys 1951; 30: 217-25.
- Paglia DE and Valentine WN: Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. The Journal of Laboratory and Clinical Medicine 1967; 70(1): 158-69.
- Lowry OH, Rosebrough NJ, Farr AL and Randall RJ: Protein measurement with the Folin-phenol reagent. Journal of Biological Chemistry 1951; 193: 265-75.
- Roe JH and Kuether CA: The determination of ascorbic acid in whole blood and urine through the 2, 4- dinitrophenyl hydrazine derivative of dehydroascorbic acid. J Biol Chem 1943; 147: 399.
- Zlatkis A, Zak B and Boyle AJ: A new method for the direct determination of serum cholesterol. The Journal of Laboratory and Clinical Medicine 1953; 41(3): 486-92.
- Talalay P: Hydroxysteroid dehydrogenases, in Methods in Enzymology. Academic Press, New York, 1962: 512.
- Chattopadhyay S, Pal S, Ghosh D and Debnath J: Effect of dietary co-administration of sodium selenite on sodium arsenite-induced ovarian and uterine disorders in mature albino rats. Toxicological Sciences 2003; 75(2): 412-22.
- Gopalkrishnan A and Rao MV: Amelioration by vitamin A upon arsenic-induced metabolic and neurotoxic effects Journal of Health Science 2006; 52(5): 568-77.
- Chattopadhyay S, Khatun S, Maity M, Jana S, Perveen H, Dash M, Dey A, Jana LR and Maity PP: Association of vitamin B12, lactate dehydrogenase, and regulation of NF-κB in the mitigation of sodium arsenite-induced ROS generation in uterine tissue by commercially available probiotics. Probiotics and Antimicrobial Proteins 2019; 11(1): 30-42.
- Gangopadhyay S, Sharma V, Chauhan A and Srivastava V: Potential facet for prenatal arsenic exposure paradigm: linking endocrine disruption and epigenetics The Nucleus 2019; 1-6.
- Prakash C, Soni M and Kumar V: Mitochondrial oxidative stress and dysfunction in arsenic neurotoxicity: a review. Journal of Applied Toxicology 2016; 36(2): 179-88.
- Maity M, Perveen H, Dash M, Jana S, Khatun S, Dey A, Mandal AK and Chattopadhyay S: Arjunolic acid improves the serum level of vitamin B12 and folate in the process of the attenuation of arsenic-induced uterine oxidative stress. Biological Trace Element Research 2018; 182(1): 78-90.
- Jhala DD, Nair SB and Chinoy NJ: Reversible toxicity of fluoride and arsenic in ovary of mice. Fluoride 2004; 37(2): 71-79.
- Williams AL and DeSesso JM: Comment on “Effects of in utero exposure to arsenic during the second half of gestation on reproductive end points and metabolic parameters in female CD-1 mice”. Environmental Health Perspectives 2016; 124(3): A46.
- Maity GN, Maity P, Dasgupta A, Acharya K, Dalai S and Mondal S: Structural and antioxidant studies of a new arabinoxylan from green stem Andrographis paniculata (Kalmegh). Carbohydrate Polymers 2019; 212: 297-03.
- Rao MV and Damore DM: Effects of Andrographis paniculata on arsenic-induced altered glucose homeostasis and oxidative impairment in pancreas of Swiss mice. The Bioscan 2007; 2: 77.
- Chatterjee A and Chatterji U: All‐trans retinoic acid ameliorates arsenic‐induced oxidative stress and apoptosis in the rat uterus by modulating MAPK signaling proteins. Journal of Cellular Biochemistry 2017; 118(11): 3796-09.
- Park WH, Han BR, Park HK and Kim SZ: Arsenic trioxide induces growth inhibition and death in human pulmonary artery smooth muscle cells accompanied by a mitochondrial increase and GSH depletion. Environmental Toxicology 2018; 33(8): 833-40.
- Das S, Pradhan GK, Das S, Nath D and Saha KD: Enhanced protective activity of nano formulated andrographolide against arsenic-induced liver damage. Chemico-Biological Interactions 2015; 242: 281-9.
- Polash SA, Saha T, Hossain MS and Sarker SR: Investigation of the phytochemicals, antioxidants, and antimicrobial activity of the Andrographis paniculata leaf and stem extracts. Advances in Bioscience and Biotechnology 2017; 8: 149-62.
- Adeoye BO, Akinrinde AS, Oyagbemi AA, Omobowale TO, Afolayan AJ, Adedapo AA: Phytochemical profiling, antioxidant activities and essential oil constituents of paniculata. Tropical Veterinarian 2018; 36(1): 52-64.
- Rao PR and Rathod VK: Rapid extraction of andrographolide from Andrographis paniculata by three-phase partitioning and determination of its antioxidant activity. Biocatalysis and Agricultural Biotechnology 2015; 4(4): 586-93.
- Bardi DA, Halabi MF, Hassandarvish P, Rouhollahi E, Paydar M, Moghadamtousi SZ, Al-Wajeeh NS, Ablat A, Abdullah NA and Abdulla MA: Andrographis paniculata leaf extract prevents thioacetamide-induced liver cirrhosis in rats. PLoS One 2014; 9(10): e109424.
- Sun W, Leng L, Yin Q, Xu M, Huang M, Xu Z, Zhang Y, Yao H, Wang C, Xiong C and Chen S: The genome of the medicinal plant Andrographis paniculata provides insight into the biosynthesis of the bioactive diterpenoid neoandrographolide. The Plant Journal 2019; 97(5): 841-57.
- Akhtar M, Bin Mohd Sarib M, Ismail I, Abas F, Ismail A, Lajis N and Shaari K: Anti-diabetic activity and metabolic changes induced by Andrographis paniculata plant extract in obese diabetic rats. Molecules 2016; 21(8): 1026.
- Kishore V, Sastry Yarla N, Bishayee A, Putta S, Malla R, Rao Reddy Neelapu N, Challa S, Das S, Shiralgi Y, Hegde G and Lakkappa Dhananjaya B: Multi-targeting andrographolide and its natural analogs as potential therapeutic agents. Current Topics in Medicinal Chemistry 2017; 17(8): 845-57.
- Thakur AK, Rai G, Chatterjee SS and Kumar V: Beneficial effects of an Andrographis paniculata extract and andrographolide on cognitive functions in streptozotocin-induced diabetic rats. Pharmaceutical Biology 2016; 54(9): 1528-38.
- Premanath R and Nanjaiah L: Anti-diabetic and Antioxidant potential of Andrographis paniculata leaf ethanol extract in streptozotocin-induced diabetic rats. Journal of Applied Pharmaceutical Science 2015; 5(1): 69-76.
How to cite this article:
Damore DM and Rao MV: Role of Andrographis paniculata on altered steroidogenesis and oxidative impairment in ovary of mice subjected to arsenic intoxication. Int J Pharm Sci & Res 2019; 10(10): 4501-06. doi: 10.13040/IJPSR.0975-8232.10(10).4501-06.
All © 2013 are reserved by International Journal of Pharmaceutical Sciences and Research. This Journal licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License.
Article Information
10
4501-4506
667
738
English
IJPSR
D. M. Damore * and M. V. Rao
Department of Zoology, Bhavan’s Sheth R. A. College of Science, Gujarat University, Ahmedabad, Gujarat, India.
dimpledamore@gmail.com
17 January 2019
26 July 2019
03 September 2019
10.13040/IJPSR.0975-8232.10(10).4501-06
01 October 2019